Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Catalyst Grant: Post Market Drug Safety and Effectiveness

University of Calgary

$66,826.00

Post Market Drug Safety and Effectiveness of Atypical Antipsychotics in Children With Disruptive Behaviour Disorders, Mood Disorders and Developmental Disorders

FY 2009-10

Summary
Mental health disorders occur in approximately 1 in 3 Canadian children. The use of prescription medications to treat mental health disorders in children is increasing, and information on the long term safety and effectiveness of these treatments is scarce. The second generation or atypical antipsychotics, a class of drugs used to treat children with various mental health disorders, are known to cause weight gain and cholesterol abnormalities in adults. More information is needed on the use of these medications in children. The proposed research project aims to study prescription rates of second generation antipsychotics for children by Canadian physicians and to develop an evidence based standardized procedure for the safe monitoring of these medications in children. The protocol will be implemented in a group of children in two different provinces for evaluation of feasibility. The researchers will plan and coordinate a long term study on the safety and effectiveness of atypical antipsychotic medications in children in order to further refine and improve evidence based recommendations for their use.
Program
Catalyst Grant: Post Market Drug Safety and Effectiveness
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
192604
Name
Pringsheim Tamara M
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Clinical
Prcname2
Catalyst Grant: Post Market Drug Safety and Effectiveness
Projecttitle
Post Market Drug Safety and Effectiveness of Atypical Antipsychotics in Children With Disruptive Behaviour Disorders, Mood Disorders and Developmental Disorders
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$66,826
Cihrequipment2
$0
Programname2
Catalyst Grant: Post Market Drug Safety and Effectiveness
Keyworddelim
Cohort Study; Drug Efficacy; Drug Safety; Pediatrics; Pharmacoepidemiology; Second Generation/ Atypical Antipsychotics
Abstract
Mental health disorders occur in approximately 1 in 3 Canadian children. The use of prescription medications to treat mental health disorders in children is increasing, and information on the long term safety and effectiveness of these treatments is scarce. The second generation or atypical antipsychotics, a class of drugs used to treat children with various mental health disorders, are known to cause weight gain and cholesterol abnormalities in adults. More information is needed on the use of these medications in children. The proposed research project aims to study prescription rates of second generation antipsychotics for children by Canadian physicians and to develop an evidence based standardized procedure for the safe monitoring of these medications in children. The protocol will be implemented in a group of children in two different provinces for evaluation of feasibility. The researchers will plan and coordinate a long term study on the safety and effectiveness of atypical antipsychotic medications in children in order to further refine and improve evidence based recommendations for their use.
Competitiondate
200910
Approvedterm2
1 yr 0 mth
Pinamesdelim
Pringsheim, Tamara M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $66,826~ $0~
University of Calgary - $66,826 Grant (2009-10) | Canada Spends